Today roughly 90% of healthcare spend is directed at managing symptoms. The real shift begins when payers, providers, patients and pharma all align their incentives—making early, effective care the norm, not the exception.

Addiction is no longer just a behavioral issue, it is a chronic condition involving whole-body neurochemistry. The next generation of addiction treatment platforms must move beyond medication management.

As healthcare expenditure continues to surge, AI can address challenges across the healthcare continuum.